NexImmune, Inc.
NexImmune, Inc. (NEXI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nexi · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
NexImmune, Inc.You NEXI | $0M | N/A | — | — |
 Biocept, Inc. BIOCQ | $0M | N/A | — | -$56.78 |
 Biostar Pharmaceuticals, Inc. BSPM | $0M | N/A | — | -$2.48 |
 Eloxx Pharmaceuticals, Inc. ELOX | $47M | N/A | — | -$5.34 |
 HTG Molecular Diagnostics, Inc. HTGMQ | $0M | N/A | — | -$24.28 |
 MedAvail Holdings, Inc. MDVLQ | $0M | N/A | — | -$36.20 |
 Micron Solutions, Inc. MICRD | $0M | N/A | — | -$0.41 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for NexImmune, Inc. (NEXI) measures how much investors pay for each dollar of the company's trailing earnings. NEXI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
NEXI pe ratio · 6 questionsNEXI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via NEXI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NexImmune, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09